365DisInFx™ Technology

Stay Protected.

*In-vitro testing demonstrated up to a 99.7% reduction of common pathogens on surfaces over an 8-hour period @ 3 W/m2.

Note: 99.7% kill rate achieved on MRSA only.

(Pathogens Tested: MRSA, bacteriophage MS2, Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Candida albicans and auris.)

Safe.

*Current’s disinfection technology abides by IEC photobiological safety standard 62471. Additionally, the 365nm UVA light emitted from the fixture is invisible to the human eye.

Integrated Controls.

Controls are integrated in fixtures with standard white light. Disinfection light can be controlled independently of white light using wired or wireless controls.

Periodic vs Continuous.

*24-Hour Cycle: Provides low-level, continuous disinfection kill rate through low-intensity irradiance with no disruption to workflow.

*Claims are based upon the proper installation of 8-hour fixture as detailed in Current’s installation Guide.

Note: All claims are based upon the proper installation of  fixture as detailed in Current’s installation guide.

Safer than the Sun*  

*Less than 3 minutes of exposure to direct sunlight is equivalent to the maximum amount of actinic UVA light that a person would be exposed to in a typical workday under Current’s disinfection lighting.

The actinic dose of 8 hours from our disinfecting light at:

• 10W/m2 is equal to being in direct sunlight for about 2m 40s; and
• 3W/m2 is equal to being in direct sunlight for about 50s.

Note: All claims are based upon the proper installation of fixture as detailed in Current’s installation guide.

Current's UV-A lighting follows IEC 62471 standards

IEC 62471 – Photobiological safety of lamps and lamp systems

• Actinic UV Hazard – Skin/eye exposure to UV
• Near-UV Hazard – Eye exposure to UV-A 
• Blue Light Hazard – Eye exposure to blue light 

An assessment of a hybrid lighting system that employs ultravioletA for mitigating healthcare-associated infections in a newborn intensive care unit

Lighting Research & Technology

Continuous Disinfecting: The Future of Fighting Hospital Acquired Infections

Fierce Electronics

Mechanistic insights into UV-A mediated bacterial disinfection via endogenous photosensitizers

Journal of Photochemistry and Photobiology B: Biology

Efficacy of an ultraviolet-A lighting system for continuous decontamination of health care−associated pathogens on surfaces

American Journal of Infection Control | Brief Report

Thinking outside the spectrum: Efficacy of a UV-A lighting system for passive disinfection of healthcare associated pathogens

SHEA Spring 2018 Conference; April 18-20, 2018 | Portland, OR | Livingston S, Cadnum J, Nerandzic M, Donskey CJ

Neonatology Today—UV-A in the NICU: New technology for an Old Challenge

Neonatology Today

LBU Series

Current’s Lumination® LBU Series Recessed LED Luminaires offer a conventional look similar to the LBT Series, but with significantly more capability. In addition to delivering a smooth uniform lit appearance with LED technology, LBU series also provides Current’s 365DisInFx™ disinfection lighting technology in areas where both conventional light is needed and people are present. Lab and clinical testing has shown this product has the ability to significantly reduce HAI-causing pathogens including MRSA, bacteriophage MS2, Staphylococcus aureus, Enterococcus faecalis, Escherichia coli, Acinetobacter baumannii, Pseudomonas aeruginosa, Candida albicans and auris.

Find the right product for you.